Provided by Tiger Trade Technology Pte. Ltd.

Global X Aging Population ETF

36.93
-0.0850-0.23%
Post-market: 36.990.0650+0.18%19:56 EDT
Volume:5K
Turnover:183.64K
Market Cap:91.19M
PE:- -
High:37.08
Open:37.08
Low:36.83
Close:37.01
52wk High:39.48
52wk Low:32.44
Shares:2.47M
Float Shares:2.47M
Volume Ratio:0.39
T/O Rate:0.20%
Dividend:0.33
Dividend Rate:0.89%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

MEDCAPTAIN's Hong Kong IPO: A Medical Device Empire Built on Acquisitions Faces Multiple Headwinds

Deep News
·
Sep 11

MS Cuts Novo Nordisk on Growth Prospects, Patent Expiry Risks

Reuters
·
Sep 11

Growth Without AI: 8 Stock Picks

Dow Jones
·
Sep 11

Nextbiomedical Targets Global Investors at 2026 KIS BioTech Day

TIPRANKS
·
Sep 11

Edwards Lifesciences comments on TAVR national coverage decision

TIPRANKS
·
Sep 11

Edwards Lifesciences Welcomes CMS Update to Medicare TAVR Coverage Policy

Reuters
·
Sep 11

Edwards Lifesciences Corporation - Maintains Confidence in Financial Guidance for 2026

THOMSON REUTERS
·
Sep 11

GeoVax Updates Nasdaq Listing Amid Ongoing Clinical Progress

TIPRANKS
·
Sep 11

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 11

Insight Guru Flags Valuation Flip as Merck Trades at 52.2x Operating Profit vs Lilly 25.3x

Reuters
·
Sep 11

AbbVie Declares Quarterly Cash Dividend of $1.73 a Share

Reuters
·
Sep 11

Abbvie - Declares Qtrly Cash Dividend of $1.73 Per Share

THOMSON REUTERS
·
Sep 11

AbbVie’s Eye Implant Study Delivers Fresh Real‑World Clarity for Investors

TIPRANKS
·
Sep 11

Eli Lilly is Maintained at Reduce by HSBC

Dow Jones
·
Sep 10

WELL Health Technologies Corp (WELL) Receives a Buy from Stifel Nicolaus

TIPRANKS
·
Sep 10

Eli Lilly’s GLP-1 Windfall to Fund Push into Women’s Health - Bloomberg News

Reuters
·
Sep 10

AbbVie Says Atogepant Met Primary, Secondary Endpoints in Phase 3 Menstrual Migraine Study

MT Newswires Live
·
Sep 10

U.K. Competition Watchdog Accepts Welltower's Concessions in Care Home Deal

Dow Jones
·
Sep 10

AbbVie’s atogepant shows positive Phase 3 results in menstrual migraine

TIPRANKS
·
Sep 10

Abbvie - Atogepant Safety Results Consistent with Known Profile; no New Safety Signals

THOMSON REUTERS
·
Sep 10